What The Study Did: This large population-based study found no evident differences between newborns of women who received the Pfizer-BioNTech COVID-19 vaccine (BNT162b2 messenger RNA) during pregnancy compared with those newborns of women who weren't vaccinated. Interpretation of study findings is limited by the observational design of the study.
Authors: Inbal Goldshtein, Ph.D., of Maccabi Healthcare Services in Tel Aviv, Israel, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamapediatrics.2022.0001)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2022.0001?guestAccessKey=0f8b1774-e4cf-460b-a020-52f682460eea&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=021022
JAMA Pediatrics